美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
46708-223-08	46708-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46708-223-08)
46708-224-08	46708-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46708-224-08)
46708-224-30	46708-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-30)
46708-224-90	46708-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-90)
46708-224-91	46708-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-91)
46708-223-91	46708-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-91)
46708-223-90	46708-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-90)
46708-223-30	46708-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-30)
62332-223-91	62332-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-91)
62332-224-08	62332-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	15 mg/1	8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (62332-224-08)
62332-224-30	62332-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-30)
62332-224-90	62332-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	15 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-90)
62332-224-91	62332-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	15 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-91)
62332-223-08	62332-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (62332-223-08)
62332-223-30	62332-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-30)
62332-223-90	62332-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN	DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212	N/A	ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-90)